BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37244956)

  • 1. Eribulin inhibits growth of cutaneous squamous cell carcinoma cell lines and a novel patient-derived xenograft.
    Hsu CY; Yanagi T; Maeda T; Nishihara H; Miyamoto K; Kitamura S; Tokuchi K; Ujiie H
    Sci Rep; 2023 May; 13(1):8650. PubMed ID: 37244956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
    Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
    Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Unique Panel of Patient-Derived Cutaneous Squamous Cell Carcinoma Cell Lines Provides a Preclinical Pathway for Therapeutic Testing.
    Hassan S; Purdie KJ; Wang J; Harwood CA; Proby CM; Pourreyron C; Mladkova N; Nagano A; Dhayade S; Athineos D; Caley M; Mannella V; Blyth K; Inman GJ; Leigh IM
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Huaier Inhibits Proliferation, Migration, and Invasion of Cutaneous Squamous Cell Carcinoma Cells by Inhibiting the Methylation Levels of CDKN2A and TP53.
    Wang L; Xu L; Wang Y
    Integr Cancer Ther; 2021; 20():15347354211031646. PubMed ID: 34291682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
    Fan Z; Qin J; Wang D; Geng S
    J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
    Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cucurbitacin B inhibits growth, arrests the cell cycle, and potentiates antiproliferative efficacy of cisplatin in cutaneous squamous cell carcinoma cell lines.
    Chen W; Leiter A; Yin D; Meiring M; Louw VJ; Koeffler HP
    Int J Oncol; 2010 Sep; 37(3):737-43. PubMed ID: 20664943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
    Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
    Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
    J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive Mutational and Phenotypic Characterization of New Metastatic Cutaneous Squamous Cell Carcinoma Cell Lines Reveal Novel Drug Susceptibilities.
    Perry J; Ashford B; Thind AS; Gauthier ME; Minaei E; Major G; Iyer NG; Gupta R; Clark J; Ranson M
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
    Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
    J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FGFR Inhibition Overcomes Resistance to EGFR-targeted Therapy in Epithelial-like Cutaneous Carcinoma.
    Bernat-Peguera A; Navarro-Ventura J; Lorenzo-Sanz L; da Silva-Diz V; Bosio M; Palomero L; Penin RM; Pérez Sidelnikova D; Bermejo JO; Taberna M; Vilariño N; Piulats JM; Mesia R; Viñals JM; González-Suárez E; Capella-Gutierrez S; Villanueva A; Viñals F; Muñoz P
    Clin Cancer Res; 2021 Mar; 27(5):1491-1504. PubMed ID: 33262138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD271 activation prevents low to high-risk progression of cutaneous squamous cell carcinoma and improves therapy outcomes.
    Quadri M; Tiso N; Musmeci F; Morasso MI; Brooks SR; Bonetti LR; Panini R; Lotti R; Marconi A; Pincelli C; Palazzo E
    J Exp Clin Cancer Res; 2023 Jul; 42(1):167. PubMed ID: 37443031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
    Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
    J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proline-rich 11 (PRR11) promotes the progression of cutaneous squamous cell carcinoma by activating the EGFR signaling pathway.
    Wang S; Zhang X; Lei H; Song L; Huang Y; Kang T; Zhang M; Wang N; Yang P; Feng S; Wang J; Bai R; Wang N; Wang W; Zheng Y
    Mol Carcinog; 2023 May; 62(5):613-627. PubMed ID: 36727626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. METTL3 mediated m
    Zhou R; Gao Y; Lv D; Wang C; Wang D; Li Q
    Biochem Biophys Res Commun; 2019 Jul; 515(2):310-317. PubMed ID: 31153635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of ARMC8 promotes tumorigenesis through activating Wnt/β-catenin pathway and EMT in cutaneous squamous cell carcinomas.
    Li X; Zhang C; Yuan Y; Wang Y; Lu S; Zhou Z; Zhen P; Zhou M
    J Dermatol Sci; 2021 Jun; 102(3):184-192. PubMed ID: 34016486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircRNA hsa_circ_0070934 functions as a competitive endogenous RNA to regulate HOXB7 expression by sponging miR‑1236‑3p in cutaneous squamous cell carcinoma.
    Zhang DW; Wu HY; Zhu CR; Wu DD
    Int J Oncol; 2020 Aug; 57(2):478-487. PubMed ID: 32626939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unraveling the interplay between senescent dermal fibroblasts and cutaneous squamous cell carcinoma cell lines at different stages of tumorigenesis.
    Toutfaire M; Dumortier E; Fattaccioli A; Van Steenbrugge M; Proby CM; Debacq-Chainiaux F
    Int J Biochem Cell Biol; 2018 May; 98():113-126. PubMed ID: 29550586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alkannin exerts antitumor properties in cutaneous squamous cell carcinoma by inducing apoptosis and shifting the M1/M2 polarization of tumor-associated macrophages by upregulating PTEN.
    Zhang ZZ; Wen CH; Jia M; Zhang HQ; Sun SQ
    Kaohsiung J Med Sci; 2023 Jan; 39(1):70-79. PubMed ID: 36367154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.